Whitehawk Therapeutics (WHWK) Raw Materials (2024)

Whitehawk Therapeutics' (WHWK) quarterly Raw Materials came in at $3.5 million in Q4 2024.

Whitehawk Therapeutics (WHWK) Raw Materials (2024) Analysis & Trends

Whitehawk Therapeutics (WHWK) has 1 years of Raw Materials data on file, last reported at $3.5 million in Q4 2024.

  • On a quarterly basis, Raw Materials changed N/A year-over-year to $3.5 million in Q4 2024; TTM through Dec 2024 was $3.5 million, a N/A change from a year earlier, with the FY2024 full-year figure at $3.5 million, changed N/A from the prior year.
  • Raw Materials for Q4 2024 stood at $3.5 million.
  • Over the last five years, Raw Materials for WHWK reached as high as $3.5 million in Q4 2024 and fell as low as $3.5 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Whitehawk Therapeutics 34.18 Mn 34.18 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 3.53 Mn